Board Meeting28 Jul 2026, 02:59 pm
Bharat Parenterals Board Meeting on Aug 5 to Approve Q1 FY27 Results
AI Summary
Bharat Parenterals Ltd has announced a Board of Directors meeting scheduled for August 5, 2026. The primary agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. Concurrently, the company has closed its trading window for designated persons from July 1, 2026, until 48 hours after the results declaration, in compliance with SEBI (Prohibition of Insider Trading) Regulations. The notice is also available on the company's website.
Key Highlights
- Board meeting scheduled for August 5, 2026.
- To approve Unaudited Standalone & Consolidated Financial Results for Q1 FY27.
- Trading window closed for designated persons from July 1, 2026.
- Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations.
Price Impact
More from BPLPHARMA